Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B.Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science324, 1029–1033 (2009).
Koppenol, W. H., Bounds, P. L. & Dang, C. V.Otto Warburg’s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer11, 325–337.
Cairns, R. A., Harris, I. S. & Mak, T. W.Regulation of cancer cell metabolism. Nat. Rev. Cancer11, 85–95.
Altenberg, B. & Greulich, K. O.Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics84, 1014–1020 (2004).
Majumder, P. K.et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nature Med.10, 594–601 (2004).
David, C. J., Chen, M., Assanah, M., Canoll, P. & Manley, J. L.HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature463, 364–368.
Clower, C. V.
et al. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc. Natl Acad. Sci. USA107, 1894–1899.
Christofk, H. R.et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature
452, 230–233 (2008).
Vander Heiden, M. G.et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science
Yang, W.et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature480, 118–122 (2011).
Luo, W.et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell145, 732–744 (2011).
Gao, X., Wang, H., Yang, J. J., Liu, X. & Liu, Z. R.Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell45, 598–609 (2012).
Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis. Chin. J. Cancer31, 5–7 (2012).
Yang, W.et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell150, 685–696 (2012).
Lu, Z. & Xu, S.ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life58, 621–631 (2006).
Lu, K. P. & Zhou, X. Z.The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol.8, 904–916 (2007).
Zheng, Y.et al. FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol. Cell35, 11–25 (2009).
Lufei, C. & Cao, X.Nuclear import of Pin1 is mediated by a novel sequence in the PPIase domain. FEBS Lett.583, 271–276 (2009).
Jans, D. A., Xiao, C. Y. & Lam, M. H.Nuclear targeting signal recognition: a key control point in nuclear transport?Bioessays22, 532–544 (2000).
Mason, D. A., Stage, D. E. & Goldfarb, D. S.Evolution of the metazoan-specific importin alpha gene family. J. Mol. Evol.68, 351–365 (2009).
Lu, Z., Ghosh, S., Wang, Z. & Hunter, T.Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell
4, 499–515 (2003).
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. & Thompson, C. B.The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab.7, 11–20 (2008).
Dang, C. V., Kim, J. W., Gao, P. & Yustein, J.
The interplay between MYC and HIF in cancer. Nat. Rev. Cancer
8, 51–56 (2008).
Warburg, O.On the origin of cancer cells. Science123, 309–314 (1956).
Hsu, P. P. & Sabatini, D. M.Cancer cell metabolism: Warburg and beyond. Cell134, 703–707 (2008).
Lu, Z.et al. Activation of protein kinase C triggers its ubiquitination and degradation. Mol. Cell Biol.18, 839–845 (1998).
Xia, Y.et al. c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Mol. Cell25, 219–232 (2007).
Fang, D.et al. Phosphorylation of β-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem.282, 11221–11229 (2007).